Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill children

Chimeric antigen receptor (CAR) T-cells directed against CD19 have drastically altered outcomes for children with relapsed and refractory acute lymphoblastic leukemia (r/r ALL). Pediatric patients with r/r ALL treated with CAR-T are at increased risk of both cytokine release syndrome (CRS) and sepsi...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Blood Adv
المؤلفون الرئيسيون: Diorio, Caroline, Shaw, Pamela A., Pequignot, Edward, Orlenko, Alena, Chen, Fang, Aplenc, Richard, Barrett, David M., Bassiri, Hamid, Behrens, Edward, DiNofia, Amanda M., Gonzalez, Vanessa, Koterba, Natalka, Levine, Bruce L., Maude, Shannon L., Meyer, Nuala J., Moore, Jason H., Paessler, Michele, Porter, David L., Bush, Jenny L., Siegel, Don L., Davis, Megan M., Zhang, Donglan, June, Carl H., Grupp, Stephan A., Melenhorst, J. Joseph, Lacey, Simon F., Weiss, Scott L., Teachey, David T.
التنسيق: Artigo
اللغة:Inglês
منشور في: American Society of Hematology 2020
الموضوعات:
Immunobiology and Immunotherapy
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC7594400/
https://ncbi.nlm.nih.gov/pubmed/33095872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002592
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة